Pacific Biosciences Of California | PACB - Equity Capital And Reserves


Pacific Biosciences Of California reported $36.09M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Agilent USD 6.91B 167M Dec/2025
Bruker USD 2.49B 625.6M Sep/2025
Danaher USD 52.53B 1.46B Dec/2025
General Electric Aerospace USD 18.9B 86M Dec/2025
Illumina USD 2.72B 342M Dec/2025
Myriad Genetics USD 372.8M 15.3M Sep/2025
Pacific Biosciences Of California USD 36.09M 25.4M Sep/2025
Quidel USD 1.92B 115.9M Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Standard Biotools USD 399.66M 24.88M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Waters USD 2.56B 230.55M Dec/2025